Skip to main content
Erschienen in: International Journal of Colorectal Disease 1/2020

27.11.2019 | Original Article

Neoadjuvant chemoradiation improves oncologic outcomes in low and mid clinical T3N0 rectal cancers

verfasst von: Olga A. Lavryk, Elena Manilich, Michael A. Valente, Arshiya Miriam, Emre Gorgun, Matthew F. Kalady, Sherief Shawki, Conor P. Delaney, Scott R. Steele

Erschienen in: International Journal of Colorectal Disease | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Controversial data exists in the current literature in regard to the use of neoadjuvant chemoradiation (nCRT) in patients with clinical T3N0 (cT3N0) rectal cancers, specifically based on location and relation to peritoneal reflection. We aimed to analyze the impact of nCRT on oncologic outcomes among cT3N0 rectal cancers, depending on the tumor height from anal verge (AV).

Methods

A retrospective analysis of patients with cT3N0 rectal cancers was included from a query of a prospectively maintained rectal cancer database from 1980 to 2016. Patients were divided into 3 groups based on the tumor height: low (1–5 cm from AV), mid (6–10 cm from AV), and upper (11–15 cm from AV). Patients were stratified by use of nCRT. Main outcomes: 5-year overall survival (OS), disease-free survival (DFS), cancer-specific survival (CSS), and local recurrence (LR) using Kaplan-Meier curves.

Results

Five hundred ninety-two patients were included. Overall, 364 (61.4%) patients received nCRT and 228 (38.6%) patients did not. There were 251 (43%) patients with low, 302 (51%) with mid, and 39 (7%) with upper rectal cancer. Patients with low and mid rectal cancers received nCRT more frequently than those with upper rectal cancers (68.5% and 61.2% vs 43.6%, p = 0.007). The 5-year OS was 78% and 63%, DFS—88% and 73%, LR—1% and 8% in nCRT followed by resection vs. surgery alone (p < 0.001). In regard to cancer location after nCRT compared with surgery alone, low and mid cancers had better OS, DFS, and CSS, compared with upper ones.

Conclusion

nCRT prolongs survival among patients with rectal cancer below 10 cm from AV; however, it has no effect on 5-year oncologic survival of patients with upper rectal cancer located below peritoneal reflection.
Literatur
1.
Zurück zum Zitat Tural D, Yildiz O, Elcin O, Erdamar S, Guney S, Demireli F, Buyukunal E, Serdengecti S (2014) What is the optimal treatment in clinical stage T3N0M0 rectal cancer? JBUON 19(1):97–102PubMed Tural D, Yildiz O, Elcin O, Erdamar S, Guney S, Demireli F, Buyukunal E, Serdengecti S (2014) What is the optimal treatment in clinical stage T3N0M0 rectal cancer? JBUON 19(1):97–102PubMed
2.
Zurück zum Zitat Heald RJ, Husband M, Ryall RD (1982) The mesorectum in rectal cancer surgery–the clue to pelvic recurrence? Br J Surg 69:613–616CrossRef Heald RJ, Husband M, Ryall RD (1982) The mesorectum in rectal cancer surgery–the clue to pelvic recurrence? Br J Surg 69:613–616CrossRef
3.
Zurück zum Zitat Morino M, Risio M, Bach S, Beets-Tan R, Bujko K, Panis Y, Quirke P, Rembacken B, Rullier E, Saito Y, Young-Fadok T, Allaix ME, European Association for Endoscopic Surgery, European Society of Coloproctology, European Association for Endoscopic Surgery; European Society of Coloproctology (2015) Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surg Endosc 29(4):755–773CrossRef Morino M, Risio M, Bach S, Beets-Tan R, Bujko K, Panis Y, Quirke P, Rembacken B, Rullier E, Saito Y, Young-Fadok T, Allaix ME, European Association for Endoscopic Surgery, European Society of Coloproctology, European Association for Endoscopic Surgery; European Society of Coloproctology (2015) Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surg Endosc 29(4):755–773CrossRef
4.
Zurück zum Zitat Stitzenberg KB, Sanoff HK, Penn DC, Meyers MO, Tepper JE (2013) Practice patterns and long-term survival for early-stage rectal cancer. J Clin Oncol 31(34):4276–4282CrossRef Stitzenberg KB, Sanoff HK, Penn DC, Meyers MO, Tepper JE (2013) Practice patterns and long-term survival for early-stage rectal cancer. J Clin Oncol 31(34):4276–4282CrossRef
5.
Zurück zum Zitat Bergquist J, Thiels C, Shubert C, Habermann EB, Hayman AV, Zielinski MD, Mathis KL (2016) Is chemotherapy or radiation therapy in addition to surgery beneficial for locally advanced rectal cancer in the elderly? A national cancer data base (NCBD study). World J Surg 40:447–455CrossRef Bergquist J, Thiels C, Shubert C, Habermann EB, Hayman AV, Zielinski MD, Mathis KL (2016) Is chemotherapy or radiation therapy in addition to surgery beneficial for locally advanced rectal cancer in the elderly? A national cancer data base (NCBD study). World J Surg 40:447–455CrossRef
6.
Zurück zum Zitat Kim N, Baik S, Seong J et al (2006) Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer. Ann Surg 244(6):1024–1029CrossRef Kim N, Baik S, Seong J et al (2006) Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer. Ann Surg 244(6):1024–1029CrossRef
7.
Zurück zum Zitat Lombardi R, Cuicchi D, Pinto C et al (2010) Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment? Ann Surg Onc 17:838–845CrossRef Lombardi R, Cuicchi D, Pinto C et al (2010) Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment? Ann Surg Onc 17:838–845CrossRef
8.
Zurück zum Zitat Park I, Kim J, Yu C, Lee JS, Lim SB, Lee JL, Yoon YS, Kim CW, Kim JC (2016) Preoperative chemotherapy for clinically diagnosed T3N0 rectal cancer. Surg Today 46:90–96CrossRef Park I, Kim J, Yu C, Lee JS, Lim SB, Lee JL, Yoon YS, Kim CW, Kim JC (2016) Preoperative chemotherapy for clinically diagnosed T3N0 rectal cancer. Surg Today 46:90–96CrossRef
9.
Zurück zum Zitat Balyasnikova S, Brown G (2016) Optimal imaging strategies for rectal cancer staging and ongoing management. Curr Treat Options in Oncol 17(6):32CrossRef Balyasnikova S, Brown G (2016) Optimal imaging strategies for rectal cancer staging and ongoing management. Curr Treat Options in Oncol 17(6):32CrossRef
10.
Zurück zum Zitat Videhult P, Smedh K, Lundin P, Kraaz W (2007) Magnetic resonance imaging for preoperative staging of rectal cancer in clinical practice: high accuracy in predicting circumferential margin with clinical benefit. Color Dis 9(5):412–419CrossRef Videhult P, Smedh K, Lundin P, Kraaz W (2007) Magnetic resonance imaging for preoperative staging of rectal cancer in clinical practice: high accuracy in predicting circumferential margin with clinical benefit. Color Dis 9(5):412–419CrossRef
11.
Zurück zum Zitat Guillem J, Diaz-Gonzalez J, Minsky B et al (2008) cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherpay is warranted. J Clin Oncol 26:368–373CrossRef Guillem J, Diaz-Gonzalez J, Minsky B et al (2008) cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherpay is warranted. J Clin Oncol 26:368–373CrossRef
12.
Zurück zum Zitat Akeel N, Lan N, Stocchi L, Costedio MM, Dietz DW, Gorgun E, Kalady MF, Karagkounis G, Kessler H, Remzi FH (2017) Clinically node negative, pathologically node positive rectal cancer patients who did not receive neoadjuvant therapy. J Gastrointest Surg 21:49–55CrossRef Akeel N, Lan N, Stocchi L, Costedio MM, Dietz DW, Gorgun E, Kalady MF, Karagkounis G, Kessler H, Remzi FH (2017) Clinically node negative, pathologically node positive rectal cancer patients who did not receive neoadjuvant therapy. J Gastrointest Surg 21:49–55CrossRef
13.
Zurück zum Zitat Delitto D, George T, Loftus T et al (2018) Prognostic value of clinical vs pathological stage in rectal cancer patietns receiving neoadjuvamt therapy. JNCI J Natl Cancer Inst 110(5):460–465CrossRef Delitto D, George T, Loftus T et al (2018) Prognostic value of clinical vs pathological stage in rectal cancer patietns receiving neoadjuvamt therapy. JNCI J Natl Cancer Inst 110(5):460–465CrossRef
14.
Zurück zum Zitat Gourtsoyianni S, Papanikolaou N (2016) Role of magnetic resonance imaging in primary rectal cancer-standard protocol and beyond. Semin Ultrasound CT MR 37(4):323–330CrossRef Gourtsoyianni S, Papanikolaou N (2016) Role of magnetic resonance imaging in primary rectal cancer-standard protocol and beyond. Semin Ultrasound CT MR 37(4):323–330CrossRef
15.
Zurück zum Zitat Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, Fenlon HM, Gollub MJ, Gourtsoyianni S, Halligan S, Hoeffel C, Kim SH, Laghi A, Maier A, Rafaelsen SR, Stoker J, Taylor SA, Torkzad MR, Blomqvist L (2018) Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 28(4):1465–1475CrossRef Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, Fenlon HM, Gollub MJ, Gourtsoyianni S, Halligan S, Hoeffel C, Kim SH, Laghi A, Maier A, Rafaelsen SR, Stoker J, Taylor SA, Torkzad MR, Blomqvist L (2018) Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 28(4):1465–1475CrossRef
16.
Zurück zum Zitat Hwang MR, Park JW, Kim DY et al (2010) Prognostic impact of peritonealisation in rectal cancer treated with preoperative chemoradiotherapy: extraperitoneal versus intraperitoneal rectal cancer. Radiother Oncol 94(3):353–358CrossRef Hwang MR, Park JW, Kim DY et al (2010) Prognostic impact of peritonealisation in rectal cancer treated with preoperative chemoradiotherapy: extraperitoneal versus intraperitoneal rectal cancer. Radiother Oncol 94(3):353–358CrossRef
17.
Zurück zum Zitat Delaney CP, Lavery IC, Brenner A, Hammel J, Senagore AJ, Noone RB, Fazio VW (2002) Preoperative radiotherapy improves survival for patients undergoing total mesorectal excision for stage T3 low rectal cancers. Ann Surg 236(2):203–207CrossRef Delaney CP, Lavery IC, Brenner A, Hammel J, Senagore AJ, Noone RB, Fazio VW (2002) Preoperative radiotherapy improves survival for patients undergoing total mesorectal excision for stage T3 low rectal cancers. Ann Surg 236(2):203–207CrossRef
18.
Zurück zum Zitat Huang M, Lee H, Tsai H et al (2018) Comparison of efficacy and safety of preoperative chemoradiotherapy in locally advanced upper and middle/lower rectal cancer. Radiat Oncol 13:53CrossRef Huang M, Lee H, Tsai H et al (2018) Comparison of efficacy and safety of preoperative chemoradiotherapy in locally advanced upper and middle/lower rectal cancer. Radiat Oncol 13:53CrossRef
19.
Zurück zum Zitat Marinello FG, Frasson M, Baguena G et al (2015) Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary. Dis Col Rectum 58:556–565CrossRef Marinello FG, Frasson M, Baguena G et al (2015) Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary. Dis Col Rectum 58:556–565CrossRef
20.
Zurück zum Zitat Rosenberg R, Maak M, Schuster S et al (2010) Does a rectal cancer of the upper third behave more like a colon or a rectal cancer? Dis Colon Rectum 53(5):761–770CrossRef Rosenberg R, Maak M, Schuster S et al (2010) Does a rectal cancer of the upper third behave more like a colon or a rectal cancer? Dis Colon Rectum 53(5):761–770CrossRef
21.
Zurück zum Zitat Gietelink L, Wouters M, Marijnen C, van Groningen J, van Leersum N, Beets-Tan RGH, Tollenaar RAEM, Tanis PJ, Dutch Surgical Colorectal Cancer Audit Group (2017) Changes in nationwide use of preoperative radiotherapy for rectal cancer after revision of the national colorectal cancer guideline. EJSO 43:1297–1303CrossRef Gietelink L, Wouters M, Marijnen C, van Groningen J, van Leersum N, Beets-Tan RGH, Tollenaar RAEM, Tanis PJ, Dutch Surgical Colorectal Cancer Audit Group (2017) Changes in nationwide use of preoperative radiotherapy for rectal cancer after revision of the national colorectal cancer guideline. EJSO 43:1297–1303CrossRef
22.
Zurück zum Zitat Bondeven P, Laurberg S, Hagemann-Madsen RH et al (2015) Suboptimal surgery and omission of neoadjuvant therapy for upper rectal cancer is associated with a high risk of local recurrence. Color Dis 17(3):216–224CrossRef Bondeven P, Laurberg S, Hagemann-Madsen RH et al (2015) Suboptimal surgery and omission of neoadjuvant therapy for upper rectal cancer is associated with a high risk of local recurrence. Color Dis 17(3):216–224CrossRef
23.
Zurück zum Zitat Lopez-Kostner F, Lavery IC, Hool GR et al (1998) Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery. 124(4):612–618CrossRef Lopez-Kostner F, Lavery IC, Hool GR et al (1998) Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery. 124(4):612–618CrossRef
24.
Zurück zum Zitat Park JS, Sakai Y, Simon NS et al (2016) Long-term survival and local relapse following surgery without radiotherapy for locally advanced upper rectal cancer: an international multi-institutional study. Medicine (Baltimore) 95(22):2990CrossRef Park JS, Sakai Y, Simon NS et al (2016) Long-term survival and local relapse following surgery without radiotherapy for locally advanced upper rectal cancer: an international multi-institutional study. Medicine (Baltimore) 95(22):2990CrossRef
25.
Zurück zum Zitat Lichliter WE (2015) Techniques in total mesorectal excision surgery. Clin Colon Rectal Surg 28(1):21–27CrossRef Lichliter WE (2015) Techniques in total mesorectal excision surgery. Clin Colon Rectal Surg 28(1):21–27CrossRef
26.
Zurück zum Zitat Khan MA, Ang CW, Hakeem AR (2017) The impact of tumour distance from the anal verge on clinical management and outcomes in patients having a curative resection for rectal cancer. J Gastrointest Surg 21:2056–2065CrossRef Khan MA, Ang CW, Hakeem AR (2017) The impact of tumour distance from the anal verge on clinical management and outcomes in patients having a curative resection for rectal cancer. J Gastrointest Surg 21:2056–2065CrossRef
27.
Zurück zum Zitat Lim SB, Yu CS, Hong YS, Kim TW, Kim JH, Kim JC (2012) Long-term outcomes in patients with locally advanced rectal cancer treated with preoperative chemoradiation followed by curative surgical resection. J Surg Oncol 106:659–666CrossRef Lim SB, Yu CS, Hong YS, Kim TW, Kim JH, Kim JC (2012) Long-term outcomes in patients with locally advanced rectal cancer treated with preoperative chemoradiation followed by curative surgical resection. J Surg Oncol 106:659–666CrossRef
28.
Zurück zum Zitat Peng LC, Milsom J, Garrett K et al (2014) Surveillance, epidemiology, and end results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer. Cancer Epidemiol 38:73–78CrossRef Peng LC, Milsom J, Garrett K et al (2014) Surveillance, epidemiology, and end results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer. Cancer Epidemiol 38:73–78CrossRef
29.
Zurück zum Zitat Ihn MH, Kim YH, Oh HK, Lee SY et al (2015) Effects of preoperative chemoradiotherapy on the likelihood of sphincter preservation surgery in locally advanced distal rectal cancer: a longitudinal study based on pelvic magnetic resonance imaging. Ann Surg Oncol 22:2159–2167CrossRef Ihn MH, Kim YH, Oh HK, Lee SY et al (2015) Effects of preoperative chemoradiotherapy on the likelihood of sphincter preservation surgery in locally advanced distal rectal cancer: a longitudinal study based on pelvic magnetic resonance imaging. Ann Surg Oncol 22:2159–2167CrossRef
30.
Zurück zum Zitat Sauer R, Becker H, Hohenberger W (2004) Preoerative versus postoeprative CRT for rectal cancer. The German rectal cancer study group. N Engl J Med 351:1731–1740CrossRef Sauer R, Becker H, Hohenberger W (2004) Preoerative versus postoeprative CRT for rectal cancer. The German rectal cancer study group. N Engl J Med 351:1731–1740CrossRef
31.
Zurück zum Zitat Augestad K, Keller D, Bakaki P, Rose J, Koroukian SM, Øresland T, Delaney CP (2018) The impact of rectal cancer tumor height on recurrence rates and metastatic location: a competing risk analysis of a national database. Cancer Epidemiol 53:56–64CrossRef Augestad K, Keller D, Bakaki P, Rose J, Koroukian SM, Øresland T, Delaney CP (2018) The impact of rectal cancer tumor height on recurrence rates and metastatic location: a competing risk analysis of a national database. Cancer Epidemiol 53:56–64CrossRef
Metadaten
Titel
Neoadjuvant chemoradiation improves oncologic outcomes in low and mid clinical T3N0 rectal cancers
verfasst von
Olga A. Lavryk
Elena Manilich
Michael A. Valente
Arshiya Miriam
Emre Gorgun
Matthew F. Kalady
Sherief Shawki
Conor P. Delaney
Scott R. Steele
Publikationsdatum
27.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Colorectal Disease / Ausgabe 1/2020
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-019-03452-6

Weitere Artikel der Ausgabe 1/2020

International Journal of Colorectal Disease 1/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.